Skip to main navigation

Investor Relations

July 02, 2020

Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial

June 22, 2020

Abivax provides business update on most recent achievements and announces positive results of annual ordinary and extraordinary general meeting

June 15, 2020

Abivax Receives € 5m Non-dilutive Financing from Société Générale as State Guaranteed Loan

May 25, 2020

Abivax publishes universal registration document 2020 "Document d'Enregistrement Universel"

May 25, 2020

Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial